|
시장보고서
상품코드
2075434
VNA(Vendor Neutral Archive) 시장 : 전개 방식별, 벤더 종류별, 영상 진단 종류별, 최종사용자별, 지역별Global Vendor Neutral Archive (VNA) Market, By Deployment Model, By Vendor Type, By Imaging Type, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 VNA(Vendor Neutral Archive) 시장은 2026년에 41억 8,000만 달러 규모에 달할 것으로 추정되며, 2033년까지 61억 2,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 5.6%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 41억 8,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 5.60% | 예측 금액(2033년) | 61억 2,000만 달러 |
VNA(Vendor Neutral Archive)는 여러 소스 및 모달리티에서 얻은 의료 영상 및 관련 보고서를 모든 의료 애플리케이션에서 저장, 검색, 조회할 수 있도록 하는 영상 관리 솔루션입니다. 그동안 의료기관에서는 방사선 영상을 저장하고 열람하기 위해 여러 개의 PACS 시스템을 관리해야 했으며, 그 결과 비용 증가와 기술적 복잡성이 초래되었습니다. VNA는 모든 부서, 소스 및 전문 분야의 이미지 데이터를 단일 아카이브로 통합하는 중앙 저장소를 제공합니다. 이를 통해 상호 운용성, 보편적인 접근성, 그리고 의료 연계의 최적화가 촉진됩니다.
시장 역학:
VNA(Vendor Neutral Archive) 시장의 성장은 만성 질환 유병률 상승에 따른 영상 진단 건수 증가, 중앙 집중형 의료 영상 저장 시스템에 대한 선호도 상승, 그리고 다양한 의료 제공 현장에서의 데이터 공유 개선 및 환자 치료 연계 강화의 필요성 등의 요인에 의해 주도되고 있습니다. 그러나 NVA 도입 및 유지보수에 따른 높은 비용과, 특히 소규모 의료 시설에서의 전문 지식 부족이 그 광범위한 보급을 저해하고 있습니다. 한편, 원격의료의 확대, 인공지능(AI) 통합을 가능하게 하는 기술의 발전, 그리고 예측 분석은 공급업체들에게 수익성 높은 기회를 제공하고 있습니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 VNA(Vendor Neutral Archive) 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 소개하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 VNA(Vendor Neutral Archive) 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 VNA(Vendor Neutral Archive) 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 VNA(Vendor Neutral Archive) 시장 : 전개 방식별(2021-2033년)
제5장 세계의 VNA(Vendor Neutral Archive) 시장 : 벤더 종류별(2021-2033년)
제6장 세계의 VNA(Vendor Neutral Archive) 시장 : 영상 진단 종류별(2021-2033년)
제7장 세계의 VNA(Vendor Neutral Archive) 시장 : 최종사용자별(2021-2033년)
제8장 세계의 VNA(Vendor Neutral Archive) 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 섹션
KSM 26.07.09Global Vendor Neutral Archive (VNA) Market is estimated to be valued at USD 4.18 Bn in 2026 and is expected to reach USD 6.12 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.18 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.60% | 2033 Value Projection: | USD 6.12 Bn |
Vendor neutral archive (VNA) is an image management solution that allows medical images and associated reports to be stored, queried, and retrieved by any healthcare application from multiple sources and modalities. Traditionally, healthcare organizations have had to manage multiple PACS systems to store and access radiology images which led to increased costs and technological complexities. A VNA provides a central repository that consolidates imaging data from all departments, sources, and specialties in a single archive. This facilitates interoperability, universal access, and optimized care collaboration.
Market Dynamics:
The growth of the vendor neutral archive (VNA) market is driven by factors such as rising imaging volumes due to increasing prevalence of chronic diseases, growing preferences for centralized medical imaging storage systems, and need to improve data sharing and enhance patient care coordination across various care delivery settings. However, high costs associated with the deployment and maintenance of VNAs as well as lack of expertise especially in small healthcare facilities limit their widespread adoption. Meanwhile, growing telehealth practices, technological advancements to enable artificial intelligence integration, and predictive analytics present lucrative opportunities for vendors.
Key features of the study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global vendor neutral archive (VNA) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Johnson & Johnson Private Limited, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Baxter, Bayer AG, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin , Allergan, AbbVie Inc., Abbott, Bausch Health Companies Inc. , Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, and AstraZeneca
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global vendor neutral archive (VNA) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vendor neutral archive (VNA) market
Detailed Segmentation:
- Global Vendor Neutral Archive (VNA) Market, By Deployment Model (Revenue, USD Bn, 2021 - 2033)
- On-Premise VNA
- Cloud-Based VNA
- Global Vendor Neutral Archive (VNA) Market, By Vendor Type (Revenue, USD Bn, 2021 - 2033)
- Independent Software Vendors (ISVs)
- PACS Vendors
- Infrastructure Vendors
- Global Vendor Neutral Archive (VNA) Market, By Imaging Type (Revenue, USD Bn, 2021 - 2033)
- Radiology VNAs
- Cardiology VNAs
- Pathology VNAs
- Global Vendor Neutral Archive (VNA) Market, By End-User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Care Centers
- Research and Academic Institutes
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Global Vendor Neutral Archive (VNA) Market, Key Players
- Johnson & Johnson Private Limited
- Merck & Co., Inc.
- F.Hoffmann-La Roche Ltd.
- Baxter
- Bayer AG
- Eli Lilly and Company
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Lupin
- Allergan
- AbbVie Inc.
- Abbott
- Bausch Health Companies Inc.
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- AstraZeneca
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Vendor Neutral Archive (VNA) Market, By Deployment Model
- Global Vendor Neutral Archive (VNA) Market, By Vendor Type
- Global Vendor Neutral Archive (VNA) Market, By Imaging Type
- Global Vendor Neutral Archive (VNA) Market, By End User
- Global Vendor Neutral Archive (VNA) Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing adoption of cloud-based VNA solutions
- Growing adoption of imaging equipment across healthcare facilities
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Service Offering Portfolio
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Pipeline Analysis
4. Global Vendor Neutral Archive (VNA) Market, By Deployment Model, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- On-premise VNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Cloud-based VNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
5. Global Vendor Neutral Archive (VNA) Market, By Vendor Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Independent Software Vendors (ISVs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- PACS Vendors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Infrastructure Vendors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Vendor Neutral Archive (VNA) Market, By Imaging Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Radiology VNAs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Cardiology VNAs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Pathology VNAs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Vendor Neutral Archive (VNA) Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Ambulatory Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
8. Global Vendor Neutral Archive (VNA) Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033,(US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Johnson & Johnson Private Limited
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Baxter
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Aurobindo Pharma
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lupin
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Allergan
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bausch Health Companies Inc.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mylan N.V.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
